Metropolitan Life Insurance Company (MetLife)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,731
| Closed | -$24.7K | – | 2282 |
|
2024
Q1 | $24.7K | Hold |
2,731
| – | – | ﹤0.01% | 1755 |
|
2023
Q4 | $29.7K | Hold |
2,731
| – | – | ﹤0.01% | 1726 |
|
2023
Q3 | $22K | Hold |
2,731
| – | – | ﹤0.01% | 1846 |
|
2023
Q2 | $29.7K | Buy |
+2,731
| New | +$29.7K | ﹤0.01% | 1723 |
|
2022
Q2 | – | Sell |
-2,539
| Closed | -$23.7K | – | 2452 |
|
2022
Q1 | $23.7K | Sell |
2,539
-3,581
| -59% | -$33.5K | ﹤0.01% | 2011 |
|
2021
Q4 | $72.7K | Sell |
6,120
-667
| -10% | -$7.92K | ﹤0.01% | 2623 |
|
2021
Q3 | $77.2K | Sell |
6,787
-4,049
| -37% | -$46.1K | ﹤0.01% | 2656 |
|
2021
Q2 | $194K | Buy |
10,836
+3,578
| +49% | +$64.2K | ﹤0.01% | 2160 |
|
2021
Q1 | $112K | Sell |
7,258
-949
| -12% | -$14.7K | ﹤0.01% | 2372 |
|
2020
Q4 | $100K | Hold |
8,207
| – | – | ﹤0.01% | 2359 |
|
2020
Q3 | $105K | Buy |
8,207
+678
| +9% | +$8.71K | ﹤0.01% | 2188 |
|
2020
Q2 | $76.5K | Buy |
+7,529
| New | +$76.5K | ﹤0.01% | 2402 |
|
2018
Q4 | – | Sell |
-3,382
| Closed | -$135K | – | 2580 |
|
2018
Q3 | $135K | Buy |
+3,382
| New | +$135K | ﹤0.01% | 2268 |
|